Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
WUXI PHARMATECH CAYMAN-ADR

WX

WUXI PHARMATECH CAYMAN-ADR

WUXI PHARMATECH CAYMAN-ADR 13F Holders

WX Stock Ownership Activity

# of activities:
1
AVG reported price*:
$32.86
Current price*:
-29.37%($23.21)
1 value investing guru has made changes to the WUXI PHARMATECH CAYMAN-ADR (WX) position according to the gurus' 2014 Q2 SEC quarterly report(s). The number of WX shares has been decreased by 1 super investor(s).

Which gurus or hedge funds bought WX in 2014 Q2?

According to the 2014 Q2 SEC filing(s) WUXI PHARMATECH CAYMAN-ADR (WX) has not been purchased by any super investor.
To see more about who is investing in WUXI PHARMATECH CAYMAN-ADR (WX), please go to the WX ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.